Iovance Biotherapeutics: High-Risk Cancer Stock Potential
A bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
Participate in webinars on financial planning topics led by experts. These sessions are designed to enhance your knowledge and help you make informed decisions.
17,885 articlesA bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
A healthcare-focused dividend stock surged last year, outpacing the Nasdaq and delivering solid income. Analysts see ...
A federal judge dismissed the Binance terrorism lawsuit, citing lack of direct links to specific attacks. The ruling ...
Tensions in the Strait of Hormuz have intensified, with ships stalled and crude prices rising. The ripple effects tou...
Investors are weighing bloom energy stock: buy options as the company scales its solid oxide fuel cells for AI data c...
BETTER Home & Finance teams up with Credit Karma to roll out an AI-powered refinance platform that promises fast prea...
Solmate plans a reverse stock split to fund a Solana-focused hub in the UAE, part of a broader pivot that includes ex...
The Federal Trade Commission has secured a $47 million restitution package to renters misled by undisclosed fees at I...
Investors are eyeing aemetis (amtx) 2025 earnings as the company advances its biofuels and biochemicals projects. Thi...
A federal judge blocked DOJ subpoenas aimed at Fed Chair Powell over a congressional hearing on the central bank’s HQ...
UniCredit announces a $40 billion bid for Germany’s second-largest bank with a 4% premium, but early signals point to...
Monday brought a notable move for Circle Internet Group stock as rising demand for USDC underscored the crypto-stable...